about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Cigna of­fers dis­count­ed Ste­lara biosim­i­lar, build­ing on Hu­mi­ra move

8 months ago
Pharma

Up­dat­ed: Lykos CEO Amy Emer­son re­signs

8 months ago
People

Mod­er­na’s mpox vac­cine out­per­forms ap­proved ver­sion in pre­clin­i­cal study

8 months ago
R&D
Pharma

Trans­plant biotech eGe­n­e­sis snags $191M af­ter first use of gene-edit­ed pig kid­ney

8 months ago
Financing
R&D

BioAge files for IPO, rid­ing mo­men­tum for weight loss drugs

8 months ago
Financing
R&D

Dana-Far­ber chief Lau­rie Glim­ch­er set to leave sto­ried can­cer cen­ter

8 months ago
People

ProKid­ney ax­es one Phase 3 study, aims for 'ex­pe­dit­ed ap­proval path­way' us­ing an­oth­er

8 months ago
R&D

Sanofi’s BTK in­hibitor goes 1-for-3 in key MS tri­als, slows dis­abil­i­ty pro­gres­sion

8 months ago
R&D
Pharma

Biose­cure vote slat­ed for Sep­tem­ber

8 months ago
China
FDA+

FDA’s drug eval­u­a­tion wing launch­es new AI over­sight pan­el

8 months ago
FDA+

UK gov­ern­ment part­ners with phar­ma on new £400M life sci­ence in­fu­sion

9 months ago
R&D
Pharma

Widen­ing GLP-1 cov­er­age could cost Medicare al­most $150B an­nu­al­ly, study finds

9 months ago
Pharma

Semaglu­tide may come with a high­er risk of sui­ci­dal thoughts, JA­MA study finds

9 months ago
Pharma

Wal­greens nabs $100M BAR­DA part­ner­ship to ex­pand de­cen­tral­ized clin­i­cal tri­als

9 months ago
Deals
R&D

Q&A: Lykos just cut 75% of its work­force af­ter an FDA re­jec­tion. Here’s what the CEO has to say

9 months ago
People
Pharma

Es­pe­ri­on's CMO hits the ex­it; Pfiz­er ap­points Nvidia alum as AI chief

9 months ago
People
Peer Review

Up­dat­ed: Lykos cut­ting most of staff less than a week af­ter FDA re­jec­tion

9 months ago
People
FDA+

Gilead wins FDA ac­cel­er­at­ed ap­proval of se­ladel­par af­ter ac­quir­ing it in $4.3B deal

9 months ago
Pharma
FDA+

Sanofi backs Anap­tys­Bio’s $100M of­fer­ing, help­ing cat­a­pult the biotech’s stock

9 months ago
Financing
Deals

Rivus posts a win for its ex­per­i­men­tal obe­si­ty drug in heart fail­ure pa­tients

9 months ago
R&D

Three pa­pers on MD­MA are re­tract­ed by med­ical jour­nal, just a day af­ter Lykos' FDA re­jec­tion

9 months ago
R&D
Pharma

Lykos’ MD­MA-as­sist­ed PTSD treat­ment re­ject­ed by FDA af­ter trou­bled tri­al and push­back from ex­perts

9 months ago
Pharma
FDA+

Hel­lo, neffy: FDA ap­proves first nasal spray for se­vere al­ler­gic re­ac­tions

9 months ago
Pharma
FDA+

Al­fasig­ma's PBC treat­ment Ocali­va to face an FDA ad­comm in Sep­tem­ber

9 months ago
Pharma
FDA+
First page Previous page 78910111213 Next page Last page
A service from the Financial Times